QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

NVCR

QT58NovoCure Limited
NASDAQ·Healthcare·Medical - Instruments & Supplies·USA
Latest market price
14.28
-3.57-20.00%
OverviewShort InterestFilings
NVCRQT58NovoCure Limited·NASDAQ
OverviewShort InterestFilings
14.28-20.00%
TA
Loading chart...
Screen all →
BDX+1.67%$143.98ALC+0.84%$64.68MDLN-1.32%$35.94WST+1.35%$327.95COO+1.32%$65.91BAX+2.58%$19.89ATR+0.28%$120.32RGEN-1.15%$132.02
Snapshot
Index-P/E-EPS (ttm)-
Insider Own3.61%
Shs Outstand115.82M
Perf Week-19.37%
Market Cap2.07BForward P/E-EPS next Y-1.17Insider Trans-0.16%Shs Float-Perf Month-16.05%
Enterprise Value2.21BPEG0.89EPS next Q-0.30Inst Own-Short Float-Perf Quarter17.53%
Income-175522581.00P/S3.07EPS this Y-Inst Trans-Short Ratio-Perf Half Y10.44%
Sales674.42MP/B6.16EPS next Y26.52%ROA-21.96%Short Interest-Perf YTD10.44%
Book/sh-P/C-EPS next 5Y-ROE-50.82%52W High18.92 -24.52%Perf Year-18.07%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-31.75%52W Low9.82 45.42%Perf 3Y-
Dividend Est.-EV/EBITDA-14.19Sales past 3/5Y-Gross Margin75.20%Volatility8.68% 5.46%Perf 5Y-
Dividend TTM-EV/Sales3.27EPS Y/Y TTM-Oper. Margin-27.19%ATR (14)1.17Perf 10Y-
Dividend Ex-Date-Quick Ratio2.70Sales Y/Y TTM-Profit Margin-25.66%RSI (14)36.84Recom2.47
Dividend Gr. 3/5Y-Current Ratio2.90EPS Q/Q-100.00%SMA20-16.62%Beta1.99Target Price33.00
Payout0.00%Debt/Eq0.71Sales Q/Q-SMA50-8.63%Rel Volume2.76Prev Close17.85
Employees1,488LT Debt/Eq-EarningsJul 23SMA2006.93%Avg Volume1.68MPrice14.28
IPO DateOct 01, 2015Option/ShortYes / YesEPS/Sales Surpr.-21.05% 3.57%Net Debt/EBITDA-0.89Volume4,630,072Change-20.00%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-18-26ReiteratedH.C. Wainwright$48 → $46
Feb-12-26ReiteratedH.C. Wainwright$39 → $47
Jan-13-26ReiteratedH.C. Wainwright$42 → $39
Jan-05-26ReiteratedEvercore ISI$22 → $20
Oct-30-25ReiteratedH.C. Wainwright$38 → $42
Jul-25-25DowngradeWells FargoOverweight → Equal Weight$15
Dec-02-24ReiteratedEvercore ISI$15 → $30
Dec-02-24UpgradeEvercore ISI GroupIn Line → Outperform
Oct-16-24ReiteratedH.C. Wainwright$24 → $30
Oct-16-24UpgradeHC Wainwright & Co.Neutral → Buy
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Insider Trading Volume
$15.36$13.55$11.73$9.92$8.11● Close Price0.00M0.50M1.01M1.51M2.02MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Leonard Frank XChief Executive OfficerJun 04 '26Sale17.9334,273614,635459,520Jun 05 12:00 AM
LEUNG GABRIELDirectorJun 02 '26Sale15.772,94546,44589,499Jun 03 12:00 AM
Stafford KristinDirectorJun 02 '26Sale15.772,94546,44511,324Jun 03 12:00 AM
Ocean Allyson JDirectorJun 02 '26Sale15.772,94546,44511,324Jun 03 12:00 AM
Scannell Timothy JDirectorJun 02 '26Sale15.772,94546,44514,288Jun 03 12:00 AM
HILLEMAN JERYL LDirectorJun 02 '26Sale15.772,94546,44513,861Jun 03 12:00 AM
VERNON W ANTHONYDirectorJun 02 '26Sale15.772,94546,445197,657Jun 03 12:00 AM
Hung DavidDirectorJun 02 '26Sale15.772,94546,44520,465Jun 03 12:00 AM
VERNON W ANTHONYDirectorApr 28 '26Option Exercise11.3943,000489,770200,602Apr 28 12:00 AM
Paravasthu MukundChief Operating OfficerMar 05 '26Sale13.7743,246595,67072,832Mar 05 12:00 AM
Brackmann ChristophChief Financial OfficerMar 04 '26Sale13.316,41285,314182,842Mar 05 12:00 AM
Puri Michal NathChief Human Resources OfficerMar 04 '26Sale13.311,10014,636201,322Mar 05 12:00 AM
Weinberg UriChf Medical and Innovation OfrMar 04 '26Sale13.316,41285,314267,190Mar 05 12:00 AM
Paravasthu MukundChief Operating OfficerMar 04 '26Sale13.315,37771,543116,078Mar 05 12:00 AM
Leonard Frank XChief Executive OfficerMar 04 '26Sale13.315,60774,603493,793Mar 05 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR